Date published: 2025-9-12

021-6093-6350

SCBT Portrait Logo
Seach Input

Feprazone (CAS 30748-29-9)

5.0(1)
寫評論提問

应用:
Feprazone 是细胞色素 P-450 2B 家族的诱导剂
CAS号码:
30748-29-9
分子量:
320.38
分子式:
C20H20N2O2
仅供科研使用。不可用于诊断或治疗。
* 参考分析证明 大量特定数据 (包括水 含量).

快捷链接

Feprazone is a non-steroidal, anti-inflammatory compound. Feprazone is noted to be structurally similar to phenylbutazone (sc-204843; deuterium-labelled sc-219696) and has been utilized in research studies analyzing the induction of P-450 where Feprazon was reported to induce the P450 II B family of cytochromes. Metabolization of Feprazone by CYP2B is reported to occur at two positons on the side chains of the compound through a molecular modeling of the interaction of the Feprazon and mammalian CYP2B.

Feprazone (CAS 30748-29-9) 参考文献

  1. 非普拉宗:大鼠体内 P450 II B 蛋白家族的诱导剂。  |  Smith, JN., et al. 1990. J Biochem Toxicol. 5: 9-12. PMID: 2402005
  2. 非普拉宗通过缓解 TLR4/MyD88/NF-κB 通路的激活预防游离脂肪酸 (FFA) 诱导的内皮炎症  |  Song, M., et al. 2021. ACS Omega. 6: 4850-4856. PMID: 33644593
  3. 非普拉宗在体外 3 T3-L1 细胞和体内小鼠中显示抗脂肪生成和抗肥胖能力  |  Che, L., et al. 2021. ACS Omega. 6: 6674-6680. PMID: 33748580
  4. 非普拉宗通过抑制 SOX-4/ADAMTS-5 信号通路改善 TNF-α 诱导的 Aggrecan 损失。  |  Xiong, X., et al. 2021. ACS Omega. 6: 7638-7645. PMID: 33778274
  5. 非普拉宗能缓解 IL-1β 诱导的软骨细胞衰老  |  Huang, Z., et al. 2021. ACS Omega. 6: 9442-9448. PMID: 33869924
  6. 通过AMPK/Nrf2/TLR4信号通路调节脂质代谢/氧化应激/炎症可减轻由游离脂肪酸诱发的非酒精性脂肪肝。  |  Ye, J., et al. 2022. Mar Drugs. 20: PMID: 35447899
  7. 比较非普拉宗和苯基丁氮酮对小鼠肝微粒体中睾酮羟化作用的影响  |  Morita, K., et al. 1986. Chem Pharm Bull (Tokyo). 34: 214-20. PMID: 3698130
  8. 在高效液相色谱法测定血浆中的苯基丁氮酮及其主要代谢物时的样品处理,避免化合物降解。  |  Franssen, MJ., et al. 1986. Pharm Weekbl Sci. 8: 229-33. PMID: 3763367
  9. 高压液相色谱法测定药物制剂中的非普拉宗。  |  Bonora, A. and Borea, PA. 1979. J Pharm Sci. 68: 798-800. PMID: 458589
  10. 哺乳动物 CYP2B 同工酶及其与底物, 阻抑剂和氧化还原伙伴相互作用的分子建模。  |  Lewis, DF. and Lake, BG. 1997. Xenobiotica. 27: 443-78. PMID: 9179987

订购信息

产品名称产品编号规格价格数量收藏夹

Feprazone, 200 mg

sc-279162
200 mg
$200.00